- Report
- December 2021
- 260 Pages
China
From €8585EUR$8,995USD£7,193GBP
- Report
- December 2021
- 258 Pages
Taiwan
From €8585EUR$8,995USD£7,193GBP
- Report
- December 2021
- 346 Pages
Australia
From €8585EUR$8,995USD£7,193GBP
- Report
- March 2021
- 584 Pages
United States
From €7630EUR$7,995USD£6,393GBP
- Report
- August 2018
Taiwan
From €7630EUR$7,995USD£6,393GBP
From €7630EUR$7,995USD£6,393GBP
- Report
- August 2024
- 92 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- August 2023
- 121 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- August 2022
- 74 Pages
Global
€4533EUR$4,750USD£3,798GBP
- Report
- July 2024
- 351 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- June 2022
- 303 Pages
Global
From €3298EUR$3,456USD£2,764GBP
- Report
- February 2022
- 270 Pages
Global
From €3543EUR$3,712USD£2,968GBP
- Book
- April 2014
North America

The Interbody Device market is a subset of the Orthopedic Devices market, which focuses on the treatment of musculoskeletal conditions. Interbody Devices are used to treat spinal conditions, such as degenerative disc disease, spinal stenosis, and spondylolisthesis. These devices are typically implanted between two vertebrae to provide stability and support to the spine. Interbody Devices are typically made of titanium or PEEK (polyetheretherketone) and come in a variety of shapes and sizes.
Interbody Devices are used in a variety of spinal surgeries, including anterior lumbar interbody fusion (ALIF), posterior lumbar interbody fusion (PLIF), and transforaminal lumbar interbody fusion (TLIF). These devices are designed to provide stability and support to the spine, while also allowing for fusion of the vertebrae.
Some companies in the Interbody Device market include Medtronic, Stryker, DePuy Synthes, Zimmer Biomet, Globus Medical, and NuVasive. Show Less Read more